For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

Lilly, Johnson & Johnson, Novartis and AstraZeneca have now announced manufacturing investments in the U.S., trying to ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Effective April 5, the United States imposed a 10% baseline tariff on imports from nearly all countries, excluding products from Canada and ...

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

The Trump administration is kicking off investigations into imports of pharmaceuticals and semiconductors as part of a bid to ...